9-37516043-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012166.3(FBXO10):c.2557G>A(p.Ala853Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,613,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012166.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO10 | NM_012166.3 | c.2557G>A | p.Ala853Thr | missense_variant | 10/11 | ENST00000432825.7 | NP_036298.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO10 | ENST00000432825.7 | c.2557G>A | p.Ala853Thr | missense_variant | 10/11 | 1 | NM_012166.3 | ENSP00000403802 | P1 | |
FBXO10 | ENST00000276960.7 | c.*764G>A | 3_prime_UTR_variant, NMD_transcript_variant | 9/9 | 5 | ENSP00000276960 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152252Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000804 AC: 20AN: 248632Hom.: 0 AF XY: 0.0000519 AC XY: 7AN XY: 134914
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461400Hom.: 0 Cov.: 31 AF XY: 0.0000316 AC XY: 23AN XY: 727036
GnomAD4 genome AF: 0.000131 AC: 20AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.2557G>A (p.A853T) alteration is located in exon 10 (coding exon 9) of the FBXO10 gene. This alteration results from a G to A substitution at nucleotide position 2557, causing the alanine (A) at amino acid position 853 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at